Tracheotomy With and Without Dual Antiplatelet Therapy (PDT and (D)APT)

Asklepios Neurological Clinic Bad Salzhausen

Status: Enrolling

Conditions: Tracheostomy Hemorrhage

Treatments: Device: Tracheotomy

Study type: Observational

Funder types: Other

Identifiers

NCT05058469

PDT and (D)APT

Details and patient eligibility

About

Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT.

The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who underwent Percutaneous Dilational Tracheostomy

Exclusion criteria

• none

Trial design

300 participants in 4 patient groups

Tracheotomy without antiplatelet therapy+technique 1

Treatment:

Device: Tracheotomy

Tracheotomy under antiplatelet therapy+technique 1

Treatment:

Device: Tracheotomy

Tracheotomy without antiplatelet therapy+technique 2

Treatment:

Device: Tracheotomy

Tracheotomy under antiplatelet therapy+technique 2

Treatment:

Device: Tracheotomy